Attached files
| file | filename |
|---|---|
| EX-99.1 - Rennova Health, Inc. | v207352_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
____________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): December 31,
2010
____________________
Tegal
Corporation
(Exact
Name of Registrant as Specified in Charter)
Delaware
(State or
Other Jurisdiction
of
Incorporation)
000-26824
(Commission
File
Number)
68-0370244
(I.R.S.
Employer
Identification
No.)
2201
South McDowell Boulevard
Petaluma,
CA 94954
(Address
of Principal Executive Offices)
(707)
763-5600
(Registrant’s
telephone number, including area code)
_____________________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
|
|
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain
Officers
|
On
December 31, 2010, the Board accepted the resignation of Gilbert Bellini as a
member of the Board, effective as of December 31, 2010. Mr. Bellini
wrote a letter of resignation, a copy of which is attached as Exhibit 99.1
hereto and is incorporated herein by reference. Mr. Bellini’s
resignation is not related to any disagreement with the Company’s operations,
policies or practices.
|
ITEM
9.01.
|
Financial Statements and
Exhibits.
|
(d) Exhibits
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Letter
of resignation dated December 31,
2010.
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
|
Date: January
5, 2011
|
TEGAL
CORPORATION
|
||
|
By:
|
\s\ Christine
Hergenrother
|
||
|
Name:
Title:
|
Christine
Hergenrother
Chief
Financial Officer
|
||
EXHIBIT
INDEX
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Letter
of resignation dated December 31,
2010.
|